| Tag | Content |
|---|
EnhancerAtlas ID | HS091-30327 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr20:23347740-23349390 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOS | MA0476.1 | chr20:23348594-23348605 | TCTGACTCATT | + | 6.32 | | MEF2C | MA0497.1 | chr20:23348081-23348096 | TGCTATTTTTAACTA | - | 6.23 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_11374 | chr20:23346061-23349812 | CD20 | | SE_17505 | chr20:23346174-23350127 | CD4p_CD25-_CD45RAp_Naive | | SE_18896 | chr20:23346171-23350201 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_22626 | chr20:23346382-23347972 | CD8_primiary | | SE_59652 | chr20:23308259-23348267 | Ly4 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH20I023367 | chr20 | 23348521 | 23348710 | | GH20I023366 | chr20 | 23346638 | 23347949 |
|
Enhancer Sequence | ACTCATGCTG TTGTGATTGA ATGTCTTTCC TAGATCTAGA AGGAAATGCA ATTGATTAAT 60
TTTGAAGTTG GCATCTACCA AGGTGGTGCA GGTTAAAGCC ATGATATAGC TTTTCCATCT 120
AGTAAGTGAG CAAAATGAAT AAACATACAC CCATTGCCTT GTTGCTAGTG TGCACATGGC 180
TGTGGCTTTT ATACCACCAG GCCATAGGAT CTGGCATGCA GGTCTTAGGT ATCAAGAGAT 240
ATAAAATAGT TCTTTTGTAA CCGAAATTTT TTTTTCTAAG ACTCTGTCCT AAAGAAATTG 300
TCCAACATAT GGGAAGAGCT GTATGCTATT ATCCCCCTTC TTGCTATTTT TAACTAAGAA 360
TGGGAAACAG CCTGATTGTC CAACTACAAG GAAGTGCTCT AGTCAACTCT GGTAAATCTA 420
TACCCTGGCT TATGACCCGG CTATTCAGAG TAAGGGCTCT GAATGACATG AAAAAGTCTG 480
TGCTTGGATG TTCAACTTTA AAATGCACAA TTAAGCATAC AGTTAACCTC AATTGTATTG 540
AAAACCTGCA CATAAAAGAC CAGAAGAAAA TAAGTTGTTA TATGATACAT TAAGGTAGTA 600
GGATTATCTC ATTTCTGTTT TCCAAAGTCT TTATGATTTA TTAATTATGT GACAGATAAA 660
ACTTAAGTTG GCTTTATTCT GCTTCAGCAC AGTAACCCTG AGGTTTAGAA TCTTGTGGAA 720
GATACAGAAG CATACAGCAC TGAAGTGTTC CAATTCTTCT CAGTTTCTTC TTTGCTTGCA 780
TTTTTTATTC TTACCTGTAA ACACTGGCTT ACAAGCCTCA AGTTCAAATG CATGTGAGAC 840
AGAGATGACA TGTCTCTGAC TCATTAGACA CCACATCTGT GTGATTAGAC ACCAGTTCTG 900
CTCATTCTGA AGTCATAATT CATGTCATTG AATGAAAATC TCATTTAATG TCATGAAATT 960
AGCATTTAAT GACATGCATT ATGACTACAG AATGAGTAGA ATTGTTTAAA GAAAGCTTGG 1020
GATTGGGGAC AAGGTCAGGT TATAATGAAG GATTAAGTTA GAATTGGTCC TTTGATAATA 1080
TTAACATGGT AAGATTTTAT TAAAGTCACT ATTTTTATTT TGATGTCTGT GAAATCGGGC 1140
ACAGCTAATA ATTTGGTAAG TCTGATTTGT GGGATTAAAC TACAAAAAGT GAGATATTTA 1200
AAACTCTTGT CCTACAATTC AATCAAGTTG ATTGGAGTTG CTACTCTAGA ATAGTGATAT 1260
ATATCCATTG TCAACTTCCC CTTTATTCTG ATAAAGATCC ATAGAAGTGT TCCTTTGAAA 1320
ATAATCCAGC AGTTCCTCCA AACAGAAGTT GTGAAATTAT TTTCTTGTTT GGAATGAGTA 1380
AATTTCTAAA ATGTGAGCCA GCTGAACAAA CAATACCTCT TTGATTCTAG TCAAATGGAA 1440
TTTTTCTTGC AATTTCCAAG GATATTTTAC ACCAACTTTC AGTAAGTAGC AAGCATCTTA 1500
CATGAATATA TATTTTATGA TAGTTTTTAC TGGAAAATGT AACATGCTGC CTACCAAGGC 1560
ACTTTTGAGT TCACGTGGGT TTTAACAGTG GAGACCTACT GTTCCATGTG TTTTTAATGC 1620
CTGTATTGTT TATGACTTTA TTTCATTTTC 1650
|
